Neuropathic ocular pain: An important yet underevaluated feature of dry eye

Eye (Basingstoke)

Volumn 29, Issue 3, 2015, Pages 301-312

  Galor, A ^a,b   Levitt, R C ^a,c   Felix, E R ^a,c   Martin, E R ^c   Sarantopoulos, C D ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLODYNIA; CHRONIC PAIN; CHRONICITY; DRY EYE; DYSESTHESIA; ENVIRONMENTAL FACTOR; EYE PAIN; GENETIC PREDISPOSITION; HUMAN; HYPERALGESIA; INFLAMMATION; MEDLINE; NEUROPATHIC OCULAR PAIN; NEUROPATHIC PAIN; PAIN RECEPTOR; PHENOTYPE; PSYCHOGENIC PAIN; REVIEW; SENSITIZATION; SENSORY DYSFUNCTION; DRY EYE SYNDROMES; NEURALGIA;

DRY EYE SYNDROMES; EYE PAIN; HUMANS; NEURALGIA;

EID: 84924853183     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.263     Document Type: Review

References (123)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 75-92.
2. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004; 78(3): 409-416.
3. Begley CG, Chalmers RL, Mitchell GL, Nichols KK, Caffery B, Simpson T et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea 2001; 20(6): 610-618.
4. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997; 124(6): 723-728.
5. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118(9): 1264-1268.
6. Bandeen-Roche K, Munoz B, Tielsch JM, West SK, Schein OD. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 1997; 38(12): 2469-2475.
7. Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol 2000; 118(6): 819-825.
8. Brewitt H, Sistani F. Dry eye disease: the scale of the problem. Surv Ophthalmol 2001; 45(Suppl 2): S199-S202.
9. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998; 105(6): 1114-1119.
10. Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 2003; 31(3): 229-232.
11. Hikichi T, YoshidaA, Fukui Y, Hamano T, Ri M, Araki K et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995; 233(9): 555-558.
12. Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 2008; 115(11): 1982-1988.
13. Uchino M, Dogru M, Uchino Y, Fukagawa K, Shimmura S, Takebayashi T et al. Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students. Am J Ophthalmol 2008; 146(6): 925-929 e922.
14. Shimmura S, Shimazaki J, Tsubota K. Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea 1999; 18(4): 408-411.
15. Sahai A, Malik P. Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol 2005; 53(2): 87-91.
16. Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea 2006; 25(10): 1162-1167.
17. Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol 2002; 86(12): 1347-1351.
18. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 93-107.
19. Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea 2011; 30(4): 379-387.
20. Galor A, Zheng DD, Arheart KL, Lam BL, Perez VL, McCollister KE et al. Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. Cornea 2012; 31(12): 1403-1407.
21. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 2005; 46(1): 46-50.
22. Pouyeh B, Viteri E, Feuer W, Lee DJ, Florez H, Fabian JA et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol 2012; 153(6): 1061-1066 e1063.
23. Rajagopalan K, Abetz L, Mertzanis P, Espindle D, Begley C, Chalmers R et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health 2005; 8(2): 168-174.
24. De Paiva CS, Corrales RM, Villarreal AL, Farley WJ, Li DQ, Stern ME et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 2006; 83(3): 526-535.
25. Rosenthal P, Baran I, Jacobs DS. Corneal pain without stain: is it real? Ocul Surf 2009; 7(1): 28-40
26. Rosenthal P, Borsook D. The corneal pain system. Part I: the missing piece of the dry eye puzzle. Ocul Surf 2012; 10(1): 2-14.
27. Definition of pain. International Assocation for the Study of Pain website. http://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698#Pain. Accessed July 15.
28. Pergolizzi J, Ahlbeck K, Aldington D, Alon E, Coluzzi F, Dahan A et al. The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment. Curr Med Res Opin 2013; 29(9): 1127-1135.
29. Geber C, Baumgartner U, Schwab R, Muller H, Stoeter P, DieterichM et al. Revised definition of neuropathic pain and its grading system: an open case series illustrating its use in clinical practice. Am J Med 2009; 122(10 Suppl): S3-S12.
30. Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res 2003; 76(5): 521-542.
31. Guthoff RF, Wienss H, Hahnel C, Wree A. Epithelial innervation of human cornea: a three-dimensional study using confocal laser scanning fluorescence microscopy. Cornea 2005; 24(5): 608-613.
32. Belmonte C, Gallar J. Cold thermoreceptors, unexpected players in tear production and ocular dryness sensations. Invest Ophthalmol Vis Sci 2011; 52(6): 3888-3892.
33. Hirata H, Meng ID. Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease. Invest Ophthalmol Vis Sci 2010; 51(8): 3969-3976.
34. Stapleton F, Marfurt C, Golebiowski B, Rosenblatt M, Bereiter D, Begley C et al. The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology. Invest Ophthalmol Vis Sci 2013; 54(11): TFOS71-TFOS97.
35. Parra A, Madrid R, Echevarria D, del Olmo S, Morenilla-Palao C, Acosta MC et al. Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea. Nat Med 2010; 16(12): 1396-1399.
36. Okamoto K, Bereiter DF, Tashiro A, Bereiter DA. Ocular surface-evoked Fos-like immunoreactivity is enhanced in trigeminal subnucleus caudalis by prior exposure to endotoxin. Neuroscience 2009; 159(2): 787-794.
37. Kurose M, Meng ID. Corneal dry-responsive neurons in the spinal trigeminal nucleus respond to innocuous cooling in the rat. J Neurophysiol 2013; 109(10): 2517-2522.
38. Tashiro A, Okamoto K, Chang Z, Bereiter DA. Behavioral and neurophysiological correlates of nociception in an animal model of photokeratitis. Neuroscience 2010; 169(1): 455-462.
39. Hirata H, Okamoto K, Tashiro A, Bereiter DA. A novel class of neurons at the trigeminal subnucleus interpolaris/caudalis transition region monitors ocular surface fluid status and modulates tear production. J Neurosci 2004; 24(17): 4224-4232.
40. Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocul Surf 2005; 3(3): 143-154.
41. Lopez-Miguel A, Teson M, Martin-Montanez V, Enriquez-de-Salamanca A, Stern ME, Calonge M et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am J Ophthalmol 2014; 157(4): 788-798 e782.
42. Teson M, Gonzalez-Garcia MJ, Lopez-Miguel A, Enriquez-de-Salamanca A, Martin-Montanez V, Benito MJ et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci 2013; 54(3): 2093-2099.
43. Lu P, Chen X, Liu X, Yu L, Kang Y, Xie Q et al. Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China. Cornea 2008; 27(5): 545-551.
44. Versura P, Profazio V, CelliniM, Torreggiani A, Caramazza R. Eye discomfort and air pollution. Ophthalmologica 1999; 213(2): 103-109.
45. Longo BM. The Kilauea Volcano adult health study. Nurs Res 2009; 58(1): 23-31.
46. Douwes J, McLean D, Slater T, Pearce N. Asthma and other respiratory symptoms in New Zealand pine processing sawmill workers. Am J Ind Med 2001; 39(6): 608-615.
47. Zuskin E, Mustajbegovic J, Schachter EN, Kern J, Doko-Jelinic J, Godnic-Cvar J. Respiratory findings in workers employed in the brick-manufacturing industry. J Occup Environ Med 1998; 40(9): 814-820.
48. Bulbulia A, Shaik R, Khan N, Vayej S, Kistnasamy B, Page T. Ocular health status of chemical industrial workers. Optom Vis Sci 1995; 72(4): 233-240.
49. Galor A, Kumar N, Feuer W, Lee DJ. Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology 2014; 121(4): 972-973 e971.
50. Shim J, Park C, Lee HS, Park MS, Lim HT, Chauhan S et al. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology 2012; 119(11): 2211-2219.
51. SternME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC et al. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Invest Ophthalmol Vis Sci 2002; 43(8): 2609-2614.
52. Lee SY, Han SJ, Nam SM, Yoon SC, Ahn JM, Kim TI et al. Analysis of tear cytokines and clinical correlations in sjogren syndrome dry eye patients and non-sjogren syndrome dry eye patients. Am J Ophthalmol 2013; 156(2): 247-253 e241.
53. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009; 28(9): 1023-1027.
54. Wakamatsu TH, Dogru M, Matsumoto Y, Kojima T, Kaido M, Ibrahim OM et al. Evaluation of lipid oxidative stress status in Sjogren syndrome patients. Invest Ophthalmol Vis Sci 2013; 54(1): 201-210.
55. He J, Bazan HE. Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids 2010; 82(4-6): 319-325.
56. Lambiase A, Micera A, Pellegrini G, Merlo D, Rama P, De Luca M et al. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest Ophthalmol Vis Sci 2009; 50(10): 4622-4630.
57. Lambiase A, Micera A, Sacchetti M, Cortes M, Mantelli F, Bonini S. Alterations of tear neuromediators in dry eye disease. Arch Ophthalmol 2011; 129 (8): 981-986.
58. Chotikavanich S, de Paiva CS, Li de Q, Chen JJ, Bian F, Farley WJ et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009; 50(7): 3203-3209.
59. rd WF, Latkany R, Tauber S, Starr C, Friedberg M et al. Sensitivity and specificity of a point-of- care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 2013; 131(1): 24-28.
60. Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011; 111(10): 5922-5943.
61. Parra A, Gonzalez-Gonzalez O, Gallar J, Belmonte C. Tear fluid hyperosmolality increases nerve impulse activity of cold thermoreceptor endings of the cornea. Pain 2014; 155(8): 1481-1491.
62. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1-32.
63. Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol 2013; 6(6): 811-816.
64. Brignole-Baudouin F, Baudouin C, Aragona P, Rolando M, Labetoulle M, Pisella PJ et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 2011; 89(7): e591-e597.
65. Cortina MS, Bazan HE. Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care 2011; 14(2): 132-137.
66. Cortina MS, He J, Li N, Bazan NG, Bazan HE. Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest Ophthalmol Vis Sci 2010; 51(2): 804-810.
67. Cortina MS, He J, Li N, Bazan NG, Bazan HE. Recovery of corneal sensitivity, calcitonin gene-related peptide-positive nerves, and increased wound healing induced by pigment epithelial-derived factor plus docosahexaenoic acid after experimental surgery. Arch Ophthalmol 2012; 130(1): 76-83.
68. Cortina MS, He J, Russ T, Bazan NG, Bazan HE. Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery. Invest Ophthalmol Vis Sci 2013; 54(6): 4109-4116.
69. de Paiva CS, Schwartz CE, Gjorstrup P, Pflugfelder SC. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 2012; 31(11): 1299-1303.
70. Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther 2010; 26(5): 431-439.
71. Nelson JW, Leigh NJ, Mellas RE, McCall AD, Aguirre A, Baker OJ. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am J Physiol Cell Physiol 2014; 306(2): C178-C185.
72. Mirakaj V, Dalli J, Granja T, Rosenberger P, Serhan CN. Vagus nerve controls resolution and pro-resolving mediators of inflammation. J Exp Med 2014; 211(6): 1037-1048.
73. Galor A, Feuer W, Lee DJ, Florez H, Venincasa VD, Perez VL. Ocular surface parameters in older male veterans. Invest Ophthalmol Vis Sci 2013; 54(2): 1426-1433.
74. Smart KM, Blake C, Staines A, Doody C. Self-reported pain severity, quality of life, disability, anxiety and depression in patients classified with 'nociceptive', 'peripheral neuropathic' and 'central sensitisation' pain. The discriminant validity of mechanisms-based classifications of low back (+ /-leg) pain. Man Ther 2012; 17(2): 119-125.
75. Galor A, Feuer W, Lee DJ, Florez H, Carter D, Pouyeh B et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol 2011; 152(3): 377-384 e372.
76. Galor A, Feuer W, Lee DJ, Florez H, Faler AL, Zann KL et al. Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol 2012; 154(2): 340-346 e342.
77. Fernandez CA, Galor A, Arheart KL, Musselman DL, Venincasa VD, Florez HJ et al. Dry eye syndrome, posttraumatic stress disorder, and depression in an older male veteran population. Invest Ophthalmol Vis Sci 2013; 54(5): 3666-3672.
78. Labbe A, Wang YX, Jie Y, Baudouin C, Jonas JB, Xu L. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol 2013; 97(11): 1399-1403.
79. Wen W, Wu Y, Chen Y, Gong L, Li M, Chen X et al. Dry eye disease in patients with depressive and anxiety disorders in Shanghai. Cornea 2012; 31(6): 686-692.
80. Kim KW, Han SB, Han ER, Woo SJ, Lee JJ, Yoon JC et al. Association between depression and dry eye disease in an elderly population. Invest Ophthalmol Vis Sci 2011; 52(11): 7954-7958.
81. Vehof J, Kozareva D, Hysi PG, Harris J, Nessa A, Williams FK et al. Relationship between dry eye symptoms and pain sensitivity. JAMA Ophthalmol 2013; 131(10): 1304-1308.
82. Woolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 2004; 74 (21): 2605-2610.
83. Waxman SG, Zamponi GW. Regulating excitability of peripheral afferents: emerging ion channel targets. Nat Neurosci 2014; 17(2): 153-163.
84. Sarantopoulos C. Burning mouth syndrome: a misunderstood, underinvestigated, and undertreated clinical challenge. Reg Anesth Pain Med 2013; 38(5): 378-379.
85. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W. Genetic architecture of human pain perception. Trends Genet 2007; 23(12): 605-613.
86. CostiganM, Belfer I, Griffin RS, Dai F, Barrett LB, Coppola G et al. Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 2010; 133(9): 2519-2527.
87. Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother 2009; 9(5): 723-744.
88. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125(3): 216-224.
89. McLean SA, Diatchenko L, Lee YM, Swor RA, Domeier RM, Jones JS et al. Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain 2011; 12(1): 101-107.
90. Erdal ME, Herken H, Yilmaz M, Bayazit YA. Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci 2001; 188(1-2): 99-101.
91. Kim H, Mittal DP, Iadarola MJ, Dionne RA. Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet 2006; 43(8): e40.
92. Dai F, Belfer I, Schwartz CE, Banco R, Martha JF, Tighioughart H et al. Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J 2010; 10(11): 949-957.
93. Armero P, Muriel C, Santos J, Sanchez-Montero FJ, Rodriguez RE, Gonzalez-Sarmiento R. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur J Pain 2005; 9(3): 229-232.
94. Orrey DC, Bortsov AV, Hoskins JM, Shupp JW, Jones SW, Cicuto BJ et al. Catechol-O-methyltransferase genotype predicts pain severity in hospitalized burn patients. J Burn Care Res 2012; 33(4): 518-523.
95. Desmeules J, Piguet V, Besson M, Chabert J, Rapiti E, Rebsamen M et al. Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism. Health Psychol 2012; 31(2): 242-249.
96. Na KS, Mok JW, Kim JY, Joo CK. Proinflammatory gene polymorphisms are potentially associated with Korean non-Sjogren dry eye patients. Mol Vis 2011; 17: 2818-2823.
97. Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 2008; 21(5): 570-579.
98. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008; 28(20): 5189-5194.
99. Rutkowski MD, DeLeo JA. The role of cytokines in the initiation and maintenance of chronic pain. Drug News Perspect 2002; 15(10): 626-632.
100. Chalmers RL, Begley CG, Caffery B. Validation of the 5-item dry eye questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Ant Eye 2010; 33(2): 55-60.
101. Lovejoy TI, Turk DC, Morasco BJ. Evaluation of the psychometric properties of the revised short-form McGill Pain Questionnaire. J Pain 2012; 13(12): 1250-1257.
102. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004; 108(3): 248-257.
103. Hosal BM, Ornek N, Zilelioglu G, Elhan AH. Morphology of corneal nerves and corneal sensation in dry eye: a preliminary study. Eye 2005; 19(12): 1276-1279.
104. Labbe A, Alalwani H, Van Went C, Brasnu E, Georgescu D, Baudouin C. The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease. Invest Ophthalmol Vis Sci 2012; 53(8): 4926-4931.
105. Bourcier T, Acosta MC, Borderie V, Borras F, Gallar J, Bury T et al. Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci 2005; 46(7): 2341-2345.
106. Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci 2007; 48(1): 173-181.
107. Situ P, Simpson TL, Fonn D, Jones LW. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness. Invest Ophthalmol Vis Sci 2008; 49(7): 2971-2976.
108. De Paiva CS, Pflugfelder SC. Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol 2004; 137(1): 109-115.
109. Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 2004; 45(9): 3030-3035.
110. Labbe A, Liang Q, Wang Z, Zhang Y, Xu L, Baudouin C et al. Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations. Invest Ophthalmol Vis Sci 2013; 54(8): 5144-5150.
111. Shimizu K, Guo W, Wang H, Zou S, LaGraize SC, Iwata K et al. Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol Pain 2009; 5: 75.
112. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007; 27(22): 6006-6018.
113. Ren K, Dubner R. The role of trigeminal interpolaris-caudalis transition zone in persistent orofacial pain. Int Rev Neurobiol 2011; 97: 207-225.
114. Acosta MC, Berenguer-Ruiz L, Garcia-Galvez A, Perea-Tortosa D, Gallar J, Belmonte C. Changes in mechanical, chemical, and thermal sensitivity of the cornea after topical application of nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci 2005; 46(1): 282-286.
115. Huang CW, Hung TY, Liao YK, Hsu MC, Wu SN. Underlying mechanism of regulatory actions of diclofenac, a nonsteroidal anti-inflammatory agent, on neuronal potassium channels and firing: an experimental and theorethical study. J Physiol Pharmacol 2013; 64(3): 269-280.
116. Ortiz MI, Castaneda-Hernandez G, Izquierdo-Vega JA, Sanchez-Gutierrez M, Ponce-Monter HA, Granados-Soto V. Role of ATP-sensitive K + channels in the antinociception induced by non-steroidal anti-inflammatory drugs in streptozotocin-diabetic and non-diabetic rats. Pharmacol Biochem Behav 2012; 102(1): 163-169.
117. Kawano T, Zoga V, Gemes G, McCallum JB, Wu HE, Pravdic D et al. Suppressed Ca2 + /CaM/CaMKIIdependent K(ATP) channel activity in primary afferent neurons mediates hyperalgesia after axotomy. Proc Natl Acad Sci USA 2009; 106(21): 8725-8730.
118. Kawano T, Zoga V, McCallum JB, Wu HE, Gemes G, Liang MY et al. ATP-sensitive potassium currents in rat primary afferent neurons: biophysical, pharmacological properties, and alterations by painful nerve injury. Neuroscience 2009; 162(2): 431-443.
119. Pakravan M, Roshani M, Yazdani S, Faramazi A, Yaseri M. Pregabalin and gabapentin for post-photorefractive keratectomy pain: a randomized controlled trial. Eur J Ophthalmol 2012; 22(Suppl 7): S106-S113.
120. Lichtinger A, Purcell TL, Schanzlin DJ, Chayet AS. Gabapentin for postoperative pain after photorefractive keratectomy: a prospective, randomized, double-blind, placebo-controlled trial. J Refract Surg 2011; 27(8): 613-617.
121. Figueroa JD, Cordero K, Serrano-Illan M, Almeyda A, Baldeosingh K, Almaguel FG et al. Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury. Neuroscience 2013; 255: 1-18.
122. Ko GD, Nowacki NB, Arseneau L, Eitel M, Hum A. Omega-3 fatty acids for neuropathic pain: case series. Clin J Pain 2010; 26(2): 168-172.
123. Ji RR, Xu ZZ, Wang X, Lo EH. Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci 2009; 30(7): 336-340.